Risk stratification and lipid evaluation in mexican patients, evidence of lipid and cardiovascular analysis in REMECAR. The mexican registry of cardiovascular diseases (REMECAR group)

Autor: Manuel Odín De los Ríos-Ibarra, José Luis Leiva-Pons, Humberto Rodríguez-Reyes, Marco Antonio Alcocer-Gamba, Jorge Cortés-Lawrenz, Frida María Vizcaíno-Rios, Jaime Barragán-Luna, Julio Iván Farjat-Ruiz, Luis R. Virgen-Carrillo, Francisco Padilla-Padilla, Abel Pavia-López, Enrique C. Morales-Villegas, Natalie C. Ward, Leslie Marisol Lugo-Gavidia

Publikováno v: Atherosclerosis Plus, Vol 50, Iss , Pp 32-39 (2022)

Background and aims: Dyslipidaemia is a significant risk factor for cardiovascular disease in the Mexican population. This analysis aimed to describe the baseline LDL-c levels of patients presenting to cardiovascular clinics and evaluate the proporti

Externí odkaz: https://doaj.org/article/b731c2a132114e11a0c81da96326cb74

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Reduction in total recurrent cardiovascular events in acute coronary syndrome patients with low-density lipoprotein cholesterol goal

Autor: Chinwong S, Patumanond J, Chinwong D, Hall JJ, Phrommintikul A

Publikováno v: Therapeutics and Clinical Risk Management, Vol 2016, Iss Issue 1, Pp 353-360 (2016)

Surarong Chinwong,1 Jayanton Patumanond,2 Dujrudee Chinwong,1 John Joseph Hall,3 Arintaya Phrommintikul4 1Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; 2Center of Excellence in Applied Epidemiolo

Externí odkaz: https://doaj.org/article/a8d564409f24430a90efe8175e61450a

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study

Autor: Annette Kjær Ersbøll, Simone Møller Hede, Mogens Lytken Larsen, Mads Nybo, Anders Green, Marie Skov Kristensen, Gunnar Gislason, Kristian Handberg Mikkelsen

Publikováno v: BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-11 (2020)
Kristensen, M S, Green, A, Nybo, M, Hede, S M, Mikkelsen, K H, Gislason, G, Larsen, M L & Ersbøll, A K 2020, ' Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome : a Danish population-based cohort study ', BMC Cardiovascular Disorders, vol. 20, no. 1, 336 . https://doi.org/10.1186/s12872-020-01616-9
Kristensen, M S, Green, A, Nybo, M, Hede, S M, Mikkelsen, K H, Gislason, G, Larsen, M L & Ersbøll, A K 2020, ' Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome : A Danish population-based cohort study ', BMC Cardiovascular Disorders, vol. 20, 336 . https://doi.org/10.1186/s12872-020-01616-9
Kristensen, M S, Green, A, Nybo, M, Hede, S M, Mikkelsen, K H, Gislason, G, Larsen, M L & Ersbøll, A K 2020, ' Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome : a Danish population-based cohort study ', BMC Cardiovascular Disorders, vol. 20, 336 . https://doi.org/10.1186/s12872-020-01616-9
BMC Cardiovascular Disorders

Background Patients with acute coronary syndrome (ACS) are at high risk of recurrent cardiovascular (CV) event. The European guidelines recommend low-density lipoprotein cholesterol (LDL-C) levels In order to reduce the risk of further cardiac events

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85d4b541476d996edd26fe35bb07f0c6
http://link.springer.com/article/10.1186/s12872-020-01616-9